HIGHLIGHTS
- who: Charbel Elias from the Department of Internal Medicine, Division of Hematology/Oncology, Naef KBasile Cancer Institute- NKBCI, American University of Beirut Medical Center have published the article: A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO), in the Journal: (JOURNAL) of April/20,/2018
- what: This trial explores a new therapeutic approach to combine stereotactic body radiation therapy (SBRT) and immunotherapy (Nivolumab) and asses its clinical benefit and safety profile after induction in CCA. A combination of both has never been explored in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.